Background: Nosocomial infection caused by Acinetobacter baumannii has emerged as a
serious problem world-wide. Finding the suitable drug is an important priority. The aim of this …

To investigate the change of the antibiotic resistance profiles of the nosocomial
Acinetobacter baumannii isolates in intensive care units (ICUs) between the years 2008 and …

Purpose Acinetobacter baumannii is a non-fermenting aerobic gram-negative bacteria and
one of the important nosocomial pathogens, especially in intensive care units (ICUs). In …

A significant opportunistic pathogen, Acinetobacter baumannii (A. baumannii) has evolved
mechanisms of resistance to a wide variety of antimicrobials, including carbapenems. In this …

An alarming increase in the resistance rates of tigecycline and colistin among
carbapenemase-producing Acinetobacter baumannii recovered from a Greek hospital over …

Treatment of Acinetobacter baumannii has become a medical challenge because of the
increasing incidence of multiresistant strains and a lack of viable treatment alternatives. This …

Acinetobacter baumannii is an important op-portunistic pathogen that is rapidly evolving
toward multidrug resistance (MDR) and is involved in various nosocomial infections …

Sir, Acinetobacter baumannii is a significant nosocomial pathogen, in particular in ICU
patients. Their multidrug resistance, propensity for clonal spread and involvement in hospital …

Acinetobacter baumannii has become a serious concern in clinical practice owing to its
multiple resistance to antimicrobial agents. Tigecycline and colistin may be used as …

BACKGOUND: Therapeutic options are limited for infections because of Acinetobacter
baumannii and carbapenem-resistant Enterobacteriaceae (CRE). Study aim was to compare …